跳至主要内容
临床试验/IRCT20191231045965N1
IRCT20191231045965N1招募中2 期

Comparison the effects of silymarin and N-acetylcysteine on improvement of, Hepatic and renal Abnormalities in Patients with SeverePreeclampsia in post-partum

Shahre-kord University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 30 years(—)
性别
Female

入选标准

  • Maternal age is between 20 and 30 years.
  • mothers BMI is between 20 and 24.
  • Gestational age at termination of pregnancy is between 35 and 42 weeks.
  • The patient's blood pressure should be greater than 140/90 mmHg before termination of pregnancy.
  • Proteinuria, in urine random sample before pregnancy termination.
  • Lack of history of hypertension, diabetes, kidney disease, collagen vascular disease and other cardiovascular diseases.
  • The mother is nulipar and has no previous abortion or pregnancy.
  • No history of smoking or alcohol in the mother.
  • Pregnancy is single and not molar.
  • Indication of termination of pregnancy in a patient with severe preeclampsia.
  • The patient has complete consent to participate in the study and has signed the consent form.
  • No incidence of eclampsia prior to inclusion.

排除标准

  • Patient dissatisfaction to participate in the study
  • Patient with eclampsia

研究者

发起方
Shahre-kord University of Medical Sciences

相似试验